focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.60
Bid: 18.60
Ask: 18.70
Change: 0.40 (2.19%)
Spread: 0.10 (0.538%)
Open: 18.60
High: 18.60
Low: 18.60
Prev. Close: 18.25
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Quarter 2023 Update

28 Apr 2023 07:00

RNS Number : 8455X
LMS Capital PLC
28 April 2023
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28 April 2023

 

 

LMS CAPITAL PLC

First Quarter 2023 Update

 

 

LMS Capital plc (the "Company"), the listed Investment Company, provides the following update covering the three months ended 31 March 2023.

 

Financial Highlights

 

· Unaudited Net Asset Value ("NAV") at 31 March 2023 was £46.1 million (57.2p per share). This compares to £46.5 million (57.7p per share) at 31 December 2022;

· Overall portfolio net gains were £0.1 million. These comprise net underlying gains of £0.5 million (including accrued interest on Dacian) offset by unrealised foreign exchange losses of £0.4 million reflecting the weakening of the US Dollar compared to sterling in Q1; and

· Cash at 31 March 2023 was £17.5 million compared to £17.9 million at 31 December 2022.

 

Unaudited Net Asset Value at 31 March 2023

 

The 31 March 2023 NAV is summarised below:

 

Unaudited

Audited

31 March

2023

31 December

 2022

£ 000s

Mature Investment Portfolio

Quoted Investments

144

160

Unquoted Investments

6,701

6,626

Funds

13,526

14,033

20,371

20,819

New Investment Portfolio

Dacian

10,280

10,145

10,280

10,145

Total Investments

30,651

30,964

Cash

17,490

17,906

Other Net Assets/Liabilities 

(1,995)

(2,329)

Net Asset Value

46,146

46,541

 

The NAV at the end of March is based on the valuation of the Company's investments as at 31 December 2022, adjusted for transactions in the three months ended 31 March 2023, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and the latest information available from third party fund managers.

 

The £0.4 million decrease in NAV during the first quarter is comprised of the following:

· Net underlying gains of £0.5 million on the investment portfolio;

· £0.4 million of portfolio unrealised foreign exchange losses from the strengthening of sterling against the U.S. Dollar;

· £0.1 million of non-portfolio unrealised foreign exchange losses;

· £0.5 million of running costs and £0.1 million of investment related costs; and

· £0.2 million on bank interest and other income receivable.

 

Portfolio Net Underlying Gains - £0.5 million

 

Quoted Investments

 

The Company's quoted investment valuations remained flat during the first quarter.

 

Unquoted Investments

 

The Company's unquoted investments include our direct holdings in Dacian Petroleum, Medhost, Elateral and a convertible debt instrument with IDE Group Holdings. ICU Eyewear, the final asset managed by San Francisco Equity Partners was disposed of during the period resulting in a realised gain of £0.1 million.

 

Unrealised gains on the unquoted portfolio were £0.4 million during the first quarter all resulting from Medhost.

 

Dacian Petroleum had £0.3 million in investment accrued interest income during the first quarter.

 

Funds

 

The Company's fund investments include its holding in Brockton Capital Fund I, Opus Capital Venture Partners, Weber Capital Partners and five other smaller fund interests.

 

Fund unrealised net losses were £0.3 million. The principal movements were:

· Opus Capital Venture Partners - Unrealised loss of £0.8 million, driven by a reduction in the fund manager's valuation of the Fund's two principal remaining investments, primarily reflecting movements in comparable market indices;

· Brockton Capital Fund 1 - Unrealised gain of £0.3 million, reflecting the unwinding of the discount rate as the investment is valued on a discounted cash flow basis;

· Weber Capital Partners - Unrealised gain of £0.1 million due to the performance in the U.S. microcap equities held in the fund; and

· Other unrealised gains on funds of £0.1 million.

 

The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 31 December 2022 fund valuation reports except for Weber Capital Partners, which is based on 31 March 2023 valuations.

 

Liquidity and Outlook

 

Portfolio realisations were £0.3 million during the period.

 

Cash balances were £17.5 million at 31 March 2023.

 

As laid out in our Annual Report, our 2023 priorities are:

· to bring to fruition the work that has been undertaken, particularly with our real estate teams, to deploy new capital from our own balance sheet in conjunction with our co-investors;

· to support the Dacian team as it enters its second year of operation with an emphasis on its workover program to increase production; and

· to continue to manage the mature asset portfolio to optimise realisation proceeds

 

 

 

For further information please contact:

LMS Capital plc

Nick Friedlos, Managing Director

0207 935 3555

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFIPMITMTATMTJ
Date   Source Headline
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:36 pmRNSPrice Monitoring Extension
2nd Feb 20217:00 amRNSNAV and Portfolio Update
7th Jan 20211:59 pmRNSPortfolio Update
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
28th Oct 20207:00 amRNSNet Asset Value(s) 3rd Quarter 2020 update
12th Aug 20207:00 amRNSPortfolio Update
4th Aug 20209:59 amRNSHalf-year Report
25th Jun 20207:13 amRNSResults of 2020 Annual General Meeting
28th May 20201:01 pmRNSAccounts and Notice of AGM
26th May 20207:00 amRNSDISCLOSURE OF RIGHTS ATTACHED TO LISTED SECURITIES
13th May 20204:00 pmRNSHolding(s) in Company
13th May 20203:37 pmRNSDirector/PDMR Shareholding
30th Apr 202012:51 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNS1st Quarter 2020 Update
15th Apr 202011:32 amRNSFinal Results
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:03 pmRNSPrice Monitoring Extension
31st Jan 202011:31 amRNSEntry in the register of small registered UK AIFMs
30th Jan 202010:21 amRNSCompany Update and NAV Estimate as at 31 Dec 2019
20th Dec 20193:45 pmRNSDirector/PDMR Shareholding
12th Dec 20192:38 pmRNSSpecial Interim Dividend
29th Nov 20198:04 amRNSDirectorate Changes & Inv Management Arrangements
28th Nov 201912:42 pmRNSResult of GM& Resignation of Independent Directors
19th Nov 20199:32 amRNSProxy Form Relating to General Meeting on 28 Nov19
5th Nov 201912:45 pmRNSPublication of Circular &Notice of General Meeting
5th Nov 201912:07 pmRNS3rd Quarter 2019 update
27th Sep 20197:00 amRNSUpdate on investment management arrangements
14th Aug 20197:00 amRNSSale of investment in Entuity completes
2nd Aug 201912:30 pmRNSResults for the six months ended 30 June 2019
26th Jul 201910:30 amRNSReview of investment management arrangements
4th Jun 20199:00 amRNSResult of AGM
30th Apr 20197:00 amRNSNotice of AGM
30th Apr 20197:00 amRNS1st Quarter 2019 update
22nd Mar 20197:00 amRNSPreliminary Results
29th Jan 20197:00 amRNSNet Asset Value(s)
12th Nov 20187:00 amRNSTransaction notification
12th Nov 20187:00 amRNSTransaction notification
9th Nov 20185:48 pmRNSTR-1: Notification of major holdings - Replacement
9th Nov 20185:46 pmRNSTR-1: Notification of major holdings - Replacement
9th Nov 20182:31 pmRNSTR-1: Notification of major holdings
9th Nov 20182:29 pmRNSTR-1: Notification of major holdings
30th Oct 20187:00 amRNSThird quarter update
12th Sep 20181:15 pmRNSHalf-year Report
31st Jul 20187:00 amRNSNAV Estimate at 30 June 2018 and Sale of Penguin
13th Jun 20189:50 amRNSSale of Penguin
1st Jun 20187:00 amRNSHolding(s) in Company
1st Jun 20187:00 amRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.